Quality Assistance held the first meeting of its Scientific Advisory Board

On 25th November 2025, Quality Assistance held the very first meeting of their Scientific Advisory Board (SAB). This milestone strengthens the analytical and scientific support they provide to their clients throughout their drug development programmes.

For their partners and clients, the SAB adds strategic insights to our services, ensuring their analytical solutions offering stay aligned with evolving modalities, technologies and regulatory standards. It reinforces their ability to produce data and develop methods that are not only robust and compliant, but also fully adapted to the scientific challenges their clients face.

Bringing together renowned leaders from the (bio)pharmaceutical industry and academia alongside our internal scientific leaders, the SAB combines external perspective with internal expertise to sharpen the relevance and efficiency of their services. The role of the SAB is to:

• Identify and prioritise emerging therapeutic modalities, ensuring that Quality Assistance develops the analytical capabilities their clients will need tomorrow.
• Guide our investments in advanced analytical techniques and technologies so Quality Assistance can anticipate scientific and regulatory shifts before they impact development timelines.
• Strengthen our forward-looking approach, enabling Quality Assistance to provide proactive guidance

This structured collaboration enhances their ability to deliver faster more reliable and analytical solutions, supporting Quality Assistance mission to accelerate access to tomorrow’s life-changing therapies through analytical excellence and trusted partnership.